Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections
Open Access
- 1 May 2004
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 11 (3) , 608-614
- https://doi.org/10.1128/cdli.11.3.608-614.2004
Abstract
We analyzed the characteristics of the inflammatory response occurring in blood during pulmonary infections in human immunodeficiency virus (HIV)-infected patients. A prospective study of consecutive hospital admissions of HIV-infected patients with new-onset radiologic pulmonary infiltrates was carried out in a tertiary university hospital from April 1998 to May 2001. Plasma cyclic AMP receptor protein (CRP), interleukin 1β (IL-1β), IL-6, IL-8, IL-10, and tumor necrosis factor alpha (TNF-α) levels were determined at the time of admission and 4, 5, and 6 days later. Patients were included in a protocol addressed to study etiology and outcome of disease. A total of 249 episodes of infection were included, with the main diagnoses being bacterial pneumonia (BP) (118 episodes), Pneumocystis carinii pneumonia (PCP) (41 episodes), and mycobacteriosis (36 episodes). For these three patient groups, at the time of admission the median CRP and cytokine levels were as follows: CRP, 10.2, 3.8 and 5 mg/dl, respectively ( P = 0.0001); IL-8, 19, 3, and 2.9 pg/ml ( P = 0.045); and TNF-α, 46.4, 44, and 75 pg/ml, respectively ( P = 0.029). There were no significant differences in levels of IL-1β, IL-6, or IL-10 among the patient groups. A total of 23 patients died. At the time of admission, HIV-infected patients with BP had higher plasma CRP and IL-8 levels than did PCP and mycobacteriosis patients. TNF-α levels were higher in patients with mycobacteriosis. An elevated IL-8 level (>61 pg/ml) at the time of admission was an independent factor associated with higher mortality (odds ratio, 12; 95% confidence interval, 1.2 to 235.5).Keywords
This publication has 29 references indexed in Scilit:
- Innate Immunity toMycobacterium tuberculosisClinical Microbiology Reviews, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- The many faces of host responses to tuberculosisImmunology, 2001
- Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controlsThorax, 2000
- Cytokine expression in severe pneumonia: A bronchoalveolar lavage studyCritical Care Medicine, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Selective Increase in Plasma Tumor Necrosis Factor- and Concomitant Clinical Deterioration after Initiating Therapy in Patients with Severe TuberculosisThe Journal of Infectious Diseases, 1998
- Diagnostic and Prognostic Value of Interleukin-6 and C-reactive Protein in Community-acquired PneumoniaScandinavian Journal of Infectious Diseases, 1995
- Phagocyte function and cytokine production in community acquired pneumonia.Thorax, 1994
- Nonparametric Statistical Inference, 2nd Edition.Published by JSTOR ,1986